Medigen Biotechnology (3176) — Financial Flexibility Index
Medigen Biotechnology (3176) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of NT$19.87 Million (operating CF NT$-18.91 Million minus capex NT$38.78 Million) represents 0% of total liabilities (NT$1.45 Billion). Check Medigen Biotechnology PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medigen Biotechnology Financial Flexibility Index (2003–2024)
Historical Financial Flexibility Index trend for Medigen Biotechnology across 12 annual periods. See 3176 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Medigen Biotechnology (2003–2024)
Year-by-year free cash flow to debt coverage for Medigen Biotechnology. For the full company profile including market capitalisation, see market cap of Medigen Biotechnology.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.06x | NT$96.59 Million | NT$37.92 Million | NT$1.67 Billion | ▲ +139.3% |
| 2023 | -0.15x | NT$-518.48 Million | NT$-569.40 Million | NT$3.53 Billion | ▲ +47.2% |
| 2022 | -0.28x | NT$-976.29 Million | NT$-1.13 Billion | NT$3.51 Billion | ▼ -174.5% |
| 2021 | 0.37x | NT$662.00 Million | NT$517.45 Million | NT$1.77 Billion | ▲ +216.2% |
| 2020 | -0.32x | NT$-531.09 Million | NT$-671.38 Million | NT$1.65 Billion | ▼ -54.3% |
| 2019 | -0.21x | NT$-446.32 Million | NT$-560.17 Million | NT$2.14 Billion | ▲ +14.9% |
| 2018 | -0.24x | NT$-405.69 Million | NT$-529.82 Million | NT$1.66 Billion | ▼ -20.0% |
| 2017 | -0.20x | NT$-344.89 Million | NT$-455.62 Million | NT$1.69 Billion | ▼ -368.5% |
| 2016 | 0.08x | NT$97.61 Million | NT$-468.61 Million | NT$1.28 Billion | ▼ -90.3% |
| 2015 | 0.79x | NT$809.42 Million | NT$294.18 Million | NT$1.03 Billion | ▼ -51.5% |
| 2005 | 1.62x | NT$83.93 Million | NT$80.72 Million | NT$51.78 Million | ▼ -60.3% |
| 2003 | 4.08x | NT$449.42 Million | NT$445.46 Million | NT$110.16 Million | — |